| Arzerra worldwide net sales in Q3 2011 totaled GBP 11.9 million (DKK 101.4 million) Genmab expects royalty payment of DKK 20.3 million COPENHAGEN, Denmark, Oct. 26, 2011 (GLOBE NEWSWIRE) -- Genmab A/S (Copenhagen:GEN) announced today that the Arzerra(r) (ofatumumab) net sales during the third quarter of 2011 were GBP 11.9 million (approximately DKK 101.4 million). This figure consists of net sales in the U.S. of GBP 8.5 million (approximately DKK 72.2 million) and in the rest of the world...continued GNMSF GNMSY |
SmallCapUpdates provides the latest news and alerts on stocks for you. If you are looking for the latest on stocks in clean energy, medical innovation, mining, biotech, nanotech, renewable energy, internet technology or in emerging markets.
Pages
▼
No comments:
Post a Comment